Immune deficiency is a risk factor for severe COVID-19 in people living with HIV.

Christian Hoffmann José Luis CasadoGeorg HärterPilar VizcarraAna MorenoDario CattaneoPaola MeravigliaChristoph D SpinnerFarhad SchabazStephan GrunwaldCristina Gervasoni

Published in: HIV medicine (2020)

In PLWH, immune deficiency is a possible risk factor for severe COVID-19, even in the setting of virological suppression. There is no evidence for a protective effect of PIs or tenofovir alafenamide.

Keyphrases

coronavirus disease
sars cov
early onset

antiretroviral therapy
replacement therapy

hiv infected
respiratory syndrome coronavirus

hiv infected patients
drug induced